I'm not sure I'd be investing in "safer, more targeted options for non-invasive external beam radiation therapy". I think that the days for external beam radiation are numbered and rightly so. No such thing as non-invasive EB radiation in my opinion.
You're right about the multinationals though.
My hope is that the Oncosil Board is pushing for a deal with the companies that wanna be huge multinationals by taking over the traditional EB radiation space. Regardless of CE mark. Sure, CE Mark will help a transaction price, but a large company might just go straight to RCT in the US.
I'm not sure I'd be investing in "safer, more targeted options...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.210(20.6%) |
Mkt cap ! $17.49M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.24 | $1.03 | $200.2K | 169.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |